#VisualAbstract: Ofatumumab vs. teriflunomide for multiple sclerosis
1. In this double-blind, randomized phase 3 trial, patient treated with ofatumumab had a lower annualized relapse rate in multiple ...
Tag: ofatumumab
Ofatumumab may reduce annual relapse rates compared to teriflunomide in multiple sclerosis
1. In this double-blind, randomized phase 3 trial, patient treated with ofatumumab had a lower annualized relapse rate in multiple ...